Overview

The 25th Annual San Diego Heart Failure Winter Symposium - New Strategies for Detection, Prevention and Treatment of Heart Failure. This year’s meeting will provide a comprehensive overview of strategies for detecting, preventing and treating heart failure. The talks, panel discussions and case presentations will focus on best practices and recent guideline recommendations as interpreted through the eyes of a renowned faculty. Throughout the two days, the faculty will provide expert insight and personal experience as they discuss the full range of management options that are available for patients throughout the spectrum of heart failure, ranging from Stage A (asymptomatic patients with risk factors) all the way to Stage D heart failure (highly symptomatic end-stage patients). New approaches for diagnosing heart failure and identifying specific groups of patients that require special management considerations (such as amyloid, hypertrophic and genetic cardiomyopathies) will be highlighted, rationale for guideline directed medical therapies (GDMTs) will be reviewed and strategies for successful implementation will be presented.

The Symposium combines didactic talks, panel discussions, case presentations and patient perspectives to provide a full and balanced overview of relevant management issues. The four highly focused sessions that comprise this year’s Symposium will cover topics related to Populations and Patients at Risk (Session I), Amyloid Heart Disease, Infiltrative Heart Disease, Hypertrophic and Other Forms of Inherited Cardiomyopathy (Session II), Identifying and Treating Heart Failure (Session III), Cardiogenic Shock, Percutaneous Devices to Support Cardiac Function, Emerging Strategies for Preventing Sudden Cardiac Death and Advances in Catheter Based Treatment of Atrial Fibrillation and Valvular Disease (Session IV). During each session, the audience will have an opportunity to comment on the talks and question the faculty on their thoughts about the best approaches for patient management. Our goal, as always, is to provide cutting edge information in a format that will enhance adaption of the knowledge that is gained into clinical practice. 

Learning Objectives

At the conclusion of this activity, participants should be able to:

1. Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
2. Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.
3. Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.

Target Audience

This course is designed for cardiologists, internists, primary care physicians, nurses, PA’s, PharmD’s and all other allied healthcare professionals with an interest in heart failure.

Accreditation

The AAFP has reviewed 25th Annual San Diego Heart Failure Winter Symposium - New Strategies for Detection, Prevention and Treatment of Heart Failure and deemed it acceptable for up to 11.5 Live AAFP Prescribed credits. Term of Approval is from 01/17/25 to 01/18/25. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

For more information please visit the official event page.